Trial of fluoxetine added to neuroleptics for treatment-resistant schizophrenic patients
- PMID: 1969245
- DOI: 10.1176/ajp.147.4.492
Trial of fluoxetine added to neuroleptics for treatment-resistant schizophrenic patients
Abstract
Mean ratings of positive and negative symptoms and depression significantly improved in nine treatment-resistant schizophrenic patients who completed a 6-week open trial of fluoxetine added to their neuroleptics. The authors identify differences between responders and nonresponders and recommend controlled trials.
Comment in
-
Addition of fluoxetine to treatment of schizophrenic patients.Am J Psychiatry. 1991 Feb;148(2):274. Am J Psychiatry. 1991. PMID: 1670983 Clinical Trial. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
